The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Berelowitz Michael since year 2005.
The trader's CIK number is 1493383.
At the time of this reporting, Berelowitz Michael is the Director of Recro Pharma, Inc. .
(stock ticker symbol REPH).
See this page for all insider trading activities at Recro Pharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-05-12||REPH||Recro Pharma, Inc.||Option Ex||13,274||.00||0|
|2018-03-09||REPH||Recro Pharma, Inc.||Option Ex||7,500||2.47||18,525|
|2018-03-09||REPH||Recro Pharma, Inc.||Sale||7,500||10.45||78,345|
|2015-12-09||ORMP||Oramed Pharmaceuticals Inc.||Sale||700||9.44||6,608|
|2015-12-07||ORMP||Oramed Pharmaceuticals Inc.||Sale||539||8.70||4,689|
|2015-12-08||ORMP||Oramed Pharmaceuticals Inc.||Sale||761||8.70||6,620|
|2014-03-31||ORMP||Oramed Pharmaceuticals Inc.||Sale||9,434||10.50||99,057|
|2014-03-31||ORMP||Oramed Pharmaceuticals Inc.||Option Ex||9,434||4.92||46,415|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berelowitz Michael (Director of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.